Aurora Ramps Up Medical Cannabis Production In Germany With Enhanced Licenses To Expand Portfolio
Canadian medical cannabis company Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) has been granted two licenses by the Federal Institute for Drugs and Medical Devices (BfArM) under Germany's new Medical Cannabis Act (MedCanG). The company said on Thursday the license grants it continued domestic cultivation, which has been underway for two years now.
